Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhejiang Anglikang Pharmaceutical Co., Ltd.

Clinical trials sponsored by Zhejiang Anglikang Pharmaceutical Co., Ltd., explained in plain language.

Zhejiang Anglikang Pharmaceutical Co., Ltd. 002940 SZSE

A Chinese pharmaceutical company producing generic drugs and active pharmaceutical ingredients.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1

New hope for advanced cancer: ALK-N001 enters human trials

Disease control Not yet recruiting

This study tests a new drug called ALK-N001 in 190 adults with advanced solid tumors that have not responded to standard treatments. The drug is given by IV every 2 or 3 weeks. Researchers will check if it shrinks tumors, how safe it is, and how the body processes it. The goal is…

Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC